Panakes Partners SGR
Panakes Partners SGR is a Milan-based venture capital firm founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni. It was the first Italian EuVECA-registered manager and invests in early-stage life sciences, medtech and biotech companies across Europe, Israel and the United States. The firm manages Panakes Fund I and the larger Panakes Fund Purple, with a new Italian therapeutics fund launched in 2026.
Key facts
Recent exits
Coverage notes
2 funds tracked, 27 portfolio companies (26 active · 1 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
27 companiesFunds & portfolio
Every fund Panakes Partners SGR has raised, with its portfolio companies. Hand-checked from public filings.
Panakes Fund PurpleLife Sciences VC2021 · 5yr€175M13 active
Unrealized
13 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| MedTech | 2023 | ||
| Biotech | 2023 | ||
| MedTech | 2024 | ||
| MedTech | 2025 | ||
| Biotech | 2024 | ||
| MedTech | 2023 | ||
| MedTech | 2025 | ||
| Biotech | 2024 | ||
| MedTech | 2024 | ||
| Biotech | 2025 | ||
| MedTech | 2023 | ||
| Biotech | 2023 | ||
| MedTech | 2025 |
Panakes Fund ILife Sciences VCHarvesting2016 · 10yr€80M13 active · 1 realized
Unrealized
13 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Pharma | 2018 | ||
| MedTech | 2017 | ||
| MedTech | 2023 | ||
| MedTech | 2016 | ||
| MedTech | 2018 | ||
| MedTech | 2018 | ||
| MedTech | 2016 | ||
| MedTech | 2018 | ||
| MedTech | 2020 | ||
| MedTech | 2018 | ||
| MedTech | 2025 | ||
| MedTech | 2020 | ||
| MedTech | 2019 |
Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | 2016 | 2026 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on Panakes Partners SGR.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in